Education
About Us
Working with TipRanks
Follow Us
Senzime AB (SE:SEZI)
:SEZI
SEZI Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr3.60 - kr9.60
Previous CloseN/A
Volume45.51K
Average Volume (3M)379.32K
Market Cap
kr982.59M
Enterprise Valuekr781.05M
Total Cash (Recent Filing)kr62.06M
Total Debt (Recent Filing)kr21.41M
Price to Earnings (P/E)―
Beta>-0.01
Next Earnings
Nov 07, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding157,215,040
10 Day Avg. Volume472,964
30 Day Avg. Volume379,318
Financial Highlights & Ratios
PEG Ratio1.35
Price to Book (P/B)2.29
Price to Sales (P/S)0.00
P/FCF Ratio-6.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr4.97Price Target Upside-15.02% Downside
Rating ConsensusHold
Number of Analyst Covering0
Senzime AB News
PremiumCompany Announcements
Senzime’s TetraGraph System Gains Approval for Mexican Market
PremiumCompany Announcements
Senzime AB Reports Strong Q2 2025 Growth
PremiumCompany Announcements
Senzime Completes MSEK 110 Share Issue with Full SubscriptionPremiumCompany Announcements
Senzime’s Licensee Secures US and UK Approvals for HN-100 Module
PremiumCompany Announcements
Senzime AB Announces Q2 2025 Financial Report Presentation
PremiumCompany Announcements
Senzime Secures Major U.S. Hospital Contract for TetraGraph MonitorsPremiumCompany Announcements
Senzime Secures New U.S. Patent for TetraGraph SystemSEZI FAQ
What was Senzime AB’s price range in the past 12 months?
Senzime AB lowest stock price was kr3.60 and its highest was kr9.60 in the past 12 months.
What is Senzime AB’s market cap?
Senzime AB’s market cap is kr982.59M.
When is Senzime AB’s upcoming earnings report date?
Senzime AB’s upcoming earnings report date is Nov 07, 2025 which is in 107 days.
How were Senzime AB’s earnings last quarter?
Senzime AB released its earnings results on Jul 18, 2025. The company reported -kr0.22 earnings per share for the quarter, missing the consensus estimate of -kr0.17 by -kr0.05.
Is Senzime AB overvalued?
According to Wall Street analysts Senzime AB’s price is currently Overvalued.
Does Senzime AB pay dividends?
Senzime AB does not currently pay dividends.
What is Senzime AB’s EPS estimate?
Senzime AB’s EPS estimate is -0.12.
How many shares outstanding does Senzime AB have?
Senzime AB has 157,215,040 shares outstanding.
What happened to Senzime AB’s price movement after its last earnings report?
Senzime AB reported an EPS of -kr0.22 in its last earnings report, missing expectations of -kr0.17. Following the earnings report the stock price went up 6.752%.
Which hedge fund is a major shareholder of Senzime AB?
Currently, no hedge funds are holding shares in SE:SEZI
Company Description
Senzime AB
Senzime AB (SEZI) is a medical technology company focused on developing and commercializing monitoring systems for patient care. The company specializes in innovative solutions that enhance patient safety and efficiency in anesthesia and critical care. Its core product line includes systems for continuous monitoring of physiological parameters, with a strong emphasis on neuromuscular monitoring.
SEZI Company Deck
SEZI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong sales growth and successful market expansion, particularly in the U.S. and Asia. The launch of the next generation TetraGraph and successful capital raise were notable achievements. However, challenges such as currency effects, softer monitor sales in the U.S., and slower growth in Europe were acknowledged. Overall, the positive achievements outweighed the challenges.Read More>Technical Analysis
C-Rad AB Class B
―
Magle Chemoswed Holding AB
―
Sedana Medical AB
―
Vicore Pharma Holding AB
―
Xspray Pharma AB
―